One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...